NasdaqGS - Delayed Quote USD
HilleVax, Inc. (HLVX)
1.9500
-0.0200
(-1.02%)
At close: May 19 at 4:00:00 PM EDT
1.9500
0.00
(0.00%)
After hours: May 19 at 4:02:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.78 | -0.42 | -0.29 | -0.37 |
| EPS Actual | -0.66 | -0.52 | -0.26 | -0.12 |
| Difference | 0.12 | -0.1 | 0.03 | 0.25 |
| Surprise % | 15.60% | -22.51% | 10.20% | 67.12% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLVX | -- | -- | -- | -- |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 8/12/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 7/9/2024 |
| Downgrade | Stifel: Buy to Hold | 7/9/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 7/9/2024 |
| Downgrade | JP Morgan: Overweight to Neutral | 7/8/2024 |
Related Tickers
EPIX ESSA Pharma Inc.
1.7000
-0.58%
PRTC.L PureTech Health plc
128.00
-2.14%
CRGX CARGO Therapeutics, Inc.
4.0900
-0.73%
BOLT Bolt Biotherapeutics, Inc.
0.3277
+11.84%
ASMB Assembly Biosciences, Inc.
13.80
+2.83%
ANTX AN2 Therapeutics, Inc.
1.1900
-1.65%
IKNA Ikena Oncology, Inc.
1.1100
0.00%
TBPH Theravance Biopharma, Inc.
9.39
+2.07%
PMVP PMV Pharmaceuticals, Inc.
0.8740
+0.94%
RPTX Repare Therapeutics Inc.
1.3800
+2.99%